IL6 and neoplasm: To extend our findings in vivo, we examined senescence (SA-β-Gal staining), DNA damage (53BP1), NF-κB activity (IκB-α) and the SASP (IL-6) in an Hs294T xenograft tumour after MLN 8237 treatment.